Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30
Closed -$3.46K 80
2023
Q2
$3.46K Buy
+30
New +$3.41K 0.01% 77
2023
Q1
Sell
-380
Closed -$42.2K 82
2022
Q4
$42.2K Buy
380
+181
+91% +$18.5K 0.12% 58
2022
Q3
$17K Sell
199
-2,241
-92% -$200K 0.01% 84
2022
Q2
$187K Sell
2,440
-1,561
-39% -$138K 0.04% 42
2022
Q1
$328K Buy
4,001
+3,362
+526% +$265K 0.07% 41
2021
Q4
$49K Sell
639
-9,861
-94% -$785K 0.02% 65
2021
Q3
$789K Buy
10,500
+10,398
+10,194% +$791K 0.23% 24
2021
Q2
$8K Sell
102
-4
-4% -$298 ﹤0.01% 109
2021
Q1
$8K Sell
106
-39
-27% -$2.88K ﹤0.01% 87
2020
Q4
$11K Buy
+145
New +$11.1K ﹤0.01% 84

Other funds holding MRK

Mizuho Securities's MRK Position: Q3 2023 in Review

Mizuho Securities sold out of Merck (MRK) in Q3 2023, closing a stake of 30 shares — an estimated $3.46K sold.

Mizuho Securities first reported a position in MRK in Q4 2020 and held it in 10 quarters. The position peaked at $789K in Q3 2021. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Mizuho Securities reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Mizuho Securities sold 30 Merck shares in Q3 2023, an estimated $3.46K.
  • Mizuho Securities first reported a position in Merck in Q4 2020 and held it in 10 quarters.
  • Mizuho Securities's Merck position peaked at $789K in Q3 2021.
  • 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Mizuho Securities's 13F filing for Q3 2023, filed 1 Nov 2023.